A triptycene-based bis(benzimidazole) ester ligand, L3, was designed to enhance the electron donating ability of the heterocyclic nitrogen atoms relative to those of the first generation bis(benzoxazole) analogs, L1 and L2. A convergent synthesis of L3 was designed and executed. Three-component titration experiments using UV-visible spectroscopy revealed that the desired diiron(II) complex could be obtained with a 1:2:1 ratio of L3:Fe(OTf) 2 (MeCN) 2 :external carboxylate reactants. X-ray crystallographic studies of two diiron complexes derived in this manner from L3 revealed their formulas to be [Fe 2 L3(μ-OH)(μ-O 2 CR)(OTf) 2 ], where R = 2,6-bis(p-tolyl)benzoate (7) or triphenylacetate (8). The structures are similar to that of a diiron complex derived from L1, [Fe 2 L1(μ-OH)(μ-O 2 CAr Tol )(OTf) 2 ] (9) with a notable difference being that, in 7 and 8, the geometry at iron more closely resembles square-pyramidal than trigonalbipyramidal. Mössbauer spectroscopic analyses of 7 and 8 indicate the presence of high-spin diiron(II) cores. These results demonstrate the importance of substituting benzimidazole for benzoxazole for assembling biomimetic diiron complexes with syn disposition of two N-donor ligands, as found in O 2 -activating carboxylate-bridged diiron centers in biology.
Introduction
Bacterial multicomponent monooxygenases (BMMs), including soluble methane monooxygenase (sMMO), 1 toluene monooxygenase (ToMO), 2, 3 and phenol hydroxylase (PH), 4 belong to a unique family of carboxylate-bridged diiron enzymes. [5] [6] [7] [8] The diiron active sites of BMMs have an oxygen-rich coordination environment composed of terminal and bridging carboxylates, water and/or hydroxides, and two imidazole donors that bind in a syn fashion with respect to the diiron vector. Even though the active site structures among the BMM family are very similar, each enzyme catalyzes the oxidation or epoxidation of a specific set of hydrocarbon substrates.
The coordination environment of the diiron core of sMMOH is provided by a highly preorganized set of amino acid residues. The proper orientation of these coordinating residues is maintained by the predefined conformation of the folded protein. The empty active site of the apo-form of sMMOH, for example, is structurally analogous to that containing the coordinated diiron unit. 9 This high degree of preorganization is a feature common to many enzymes. 10 In addition to serving as a structural scaffold, the active site cavity also provides a hydrophobic environment where catalytic intermediates can avoid being prematurely deactivated by adventitious reactants.
The synthesis of faithful small-molecule models of the active sites of diiron enzymes is a significant challenge in bioinorganic chemistry. [11] [12] [13] [14] [15] [16] [17] In addition to providing a platform for studying the mechanisms of natural systems, biomimetic models may also function as catalysts to perform similar chemical transformations. Over the past three decades, many different ligands have been employed to mimic the diiron cores of BMMs. Among them, ligands based on tris(2-pyridylmethyl)amine (TPA) and sterically encumbering 2,6-diarylbenzoate ligands have been extensively investigated ( Figure 1) . 13, 14, 18, 19 Although much insight has been gained from studying these systems, the model compounds generally fall short of accurately replicating both the structural and electronic properties of the enzyme active site, not to mention their functions. TPA-based diiron complexes can generate intermediates close to those observed in BMMs upon reaction with dioxygen. These intermediates usually exhibit poor reactivity with hydrocarbons, which may be due to the fact that they have a low-spin rather than a high-spin electronic configuration [20] [21] [22] as a result of their nitrogen-rather than oxygen-rich coordination environments. [23] [24] [25] High-spin diiron complexes of this ligand class are more reactive. [26] [27] [28] [29] [30] Sterically encumbering 2,6-diarylbenzoate ligands form diiron complexes that closely mimic the oxygen-rich coordination sphere found in the active sites of BMMs. [31] [32] [33] [34] The use of dendrimer-appended carboxylates allowed preparation of complexes having a hydrophobic sheath, similar to the environment surrounding the diiron active sites of the BMMs. 35 Attempts to model the syn disposition of the two histidine ligands in this system, however, led only to the formation of complexes with nitrogen donors in the trans disposition. Thus, although certain structures and reactivities of the BMM active site can be modeled, no small molecule yet exists that can successfully mimic both features.
Our group has recently focused on constructing faithful structural models by using tailoredmade dinucleating ligands. A particularly challenging aspect is to model the syn disposition of the two histidine ligands. This particular orientation of nitrogen donors may be crucial for the oxidation of methane by intermediate Q of sMMOH. 22 We have prepared and reported several ligands with the goal of modeling this structural feature. 14,16,17,36 1,2-Diethynylbenzene-based scaffolds were effectively employed for this purpose. [37] [38] [39] [40] [41] The low-energy barrier to rotation about the alkynyl C-C bond, however, led to the formation of undesired metallopolymers and bis(ligand) iron complexes. 38, 42 To circumvent this problem, we recently introduced a syn N-donor macrocyclic ligand, H 2 PIM, 43 which afforded a diiron complex with remarkable structural similarity to the active site of sMMOH.
Here, we describe an advanced design of highly preorganized ligands for the synthesis of biomimetic models of the diiron active site of sMMOH ( Figure 2 ). Continuing along lines reported previously, 36 we present the synthesis of a new ligand with a triptycene backbone, L3. This molecule differs from previously reported triptycene L1 36 by replacement of the benzoxazole arms with more nucleophilic benzimidazole donors. The synthesis and structures of two carboxylate bridged diiron(II) complexes of L3 are reported, and the results are compared to those for the L1 analogue.
Experimental Section General Methods and Materials
Reagents purchased from TCI, Aldrich Chemical Co., and Alfa Aesar were used as received, unless otherwise noted. The synthesis of compound 6 was described previously. 36 Column chromatography was carried out utilizing Silicycle 60 Å, ultrapure silica gel. 1 H and 13 C NMR spectra were recorded using a 300 MHz or 500 MHz Varian Mercury spectrometer. IR spectra were measured on a ThermoNicolet Avatar 360 spectrophotometer controlled by the OMNIC software. Low-resolution electrospray ionization mass spectra were acquired on an Agilent Technologies 1100 series LC-MSD trap. High-resolution mass spectra were obtained on a Bruker Daltonics APEXIV 4.7 Tesla Fourier Transform ion cyclotron resonance mass spectrometer (FT-ICRNS) at the MIT Department of Chemistry Instrument Facility (DCIF).
X-ray Diffraction Studies
Single crystals suitable for X-ray analysis were coated with Paratone-N oil, suspended in a small fiber loop, and placed in a cooled dry N 2 gas stream on a Brüker APEX CCD X-ray diffractometer. Data were acquired using graphite monochromated Mo Kα radiation (λ = 0.71073 Å) at 100(2) K and a combination of φ and ω scans traversing their respective scanning angles at 0.5° increments for ω scans and 0.45° increments for φ scans. Data collection, indexing, reduction, and final unit cell refinement procedures were carried out using APEX2; absorption corrections were applied by using the program SADABS. All structures were solved with direct methods with SHELXS 44 and refined against F 2 on all data by full-matrix least squares with SHELXL, 45 following established refinement strategies. 46 Data collection and refinement parameters are summarized in Table 1 , and specific refinement details are given below.
For compound 7, the crystal diffracted only to a maximum 2θ value of 23.4°. A molecule of dichloromethane and diethyl ether are present in the asymmetric unit, along with the diiron complex. The diethyl ether molecule was refined with similarity restraints on the thermal ellipsoids and carbon-carbon bond lengths. The triflate ligand coordinated to Fe1 is disordered, adopting two orientations. The disorder was modeled by restraining both components to have similar bond lengths and thermal ellipsoids parameters. The occupancy factors of the disordered components were refined, constraining the sum of the occupancy factors to unity. The major component refined to an occupancy value of 0.68. The hydrogen atom of the bridging hydroxo ligand was located on a difference Fourier map and the O-H distance was constrained to 0.84 Å. The thermal ellipsoid of the hydrogen atom was constrained to be 1.5 times that of the oxygen atom to which it is attached. At the final stages of refinement, a large residual electron density peak of 4.38 e − /Å 3 remained. This peak is located 0.85 Å from H10, an atom on the triptycene backbone. The origin of this large residual electron density remains uncertain, but may reflect series termination errors owing to the low resolution and intensity of the data set.
Crystals of 8 diffracted well. The asymmetric unit consists of the diiron complex and a molecule of dichloromethane. The latter is disordered, having two orientations that were refined with similarity restraints on both the bond distances and thermal ellipsoids. The major component of this disorder refined to an occupancy factor of 0.53. The hydrogen atom of the bridging hydroxo ligand was located on a difference Fourier map and refined as described for 7. The absolute structure (Flack) parameter, refined using the racemic twin law, converged to a value of 0.395 with a standard uncertainty of 0.019, indicating that the crystal is most likely a twin with a minor domain of the opposite absolute structure comprising approximately 40% of the crystal.
Fe Mössbauer Spectroscopy
Mössbauer spectra were recorded on a MSI spectrometer (WEB Research Co.) with a 57 Co source in a Rh matrix maintained at room temperature. Solid samples were prepared by suspension in Apiezon M grease and placed in a nylon sample holder. Data were acquired at 77 K, and the isomer shift (δ) values are reported with respect to metallic iron that was used for velocity calibration at room temperature. The spectra were fit to Lorentzian lines using the WMOSS plot and fit program (WEB Research Co.).
Methyl 3-Chloro-2-nitrobenzoate (1)
Diazomethane, CH 2 N 2 , generated from Diazald and 10% NaOH in EtOH, was bubbled into a suspension of 3-chloro-2-nitrobenzoic acid (10.0g, 50 mmol) in 250 mL Et 2 O under a steam of nitrogen. The reaction was monitored by TLC until completion. The resulting solution was passed through a short pad of silica gel. The product, which was retained on the column, was eluted with acetone. After rotary evaporation of the acetone eluate, 10.6 g (99%) of methyl 3-chloro-2-nitrobenzoate (1) was obtained as a white solid. 1 
Methyl 3-(N-Methylacetamido)-2-nitrobenzoate (2)
A flask containing methyl 3-chloro-2-nitrobenzoate (1) (8.6 g, 40 mmol), Cs 2 CO 3 (15.6 g, 48 mmol, 1.2 equiv), Pd(TFA) 2 (TFA = trifluoroacetate) (664 mg, 5 mol%), and BINAP (1.25 g, 5 mol%) was evacuated and back-filled with nitrogen three times. NMethylacetamide (4.1 g, 56 mmol, 1.4 equiv) was added via syringe, followed by addition of anhydrous toluene (240 mL). The resulting mixture was heated at 80-85°C for three days under a nitrogen atmosphere. The resulting black solution was cooled to room temperature. Water (300 mL) was added and the resulting mixture was extracted with EtOAc (4 × 100 mL). The combined organic layers were washed with 10% aq HCl (50 mL) and brine (50 mL), dried over Na 2 SO 4 , filtered, and evaporated to dryness. Flash column chromatography of the resulting residue (dichloromethane: acetone = 1:0-4:1) gave 8.2 g (82%) of methyl 3-(N-methylacetamido)-2-nitrobenzoate (2) as a yellow solid. 1 H NMR (300 MHz) in CDCl 3 δ 1.81 (s, 3H), 3.14 (s, 3H), 3.91 (s, 3H), 7.55 (dd, J 1 = 1.5 Hz, J 2 = 7.8 Hz, 1H), 7.68 (t, J = 7.8 Hz, 1H), 8.10 (dd, J 1 = 1.5 Hz, J 2 = 7.8 Hz, 1H); 13 
3-(Methylamino)-2-nitrobenzoic acid (3)
A solution of methyl 3-(N-methylacetamido)-2-nitrobenzoate (2) (8.0 g, 31.7 mmol) in a mixture of 10% aq NaOH and EtOH (520 mL:200 mL) was heated at 80-85 °C for 10 h. The resulting orange-red solution was cooled to 0 °C. Concentrated HCl was added slowly to adjust the pH to 1.5-2.0. The resulting mixture was extracted with EtOAc (4 × 150 mL). The combined organic layers were washed with brine (30 mL), dried over Na 2 SO 4 , filtered, and evaporated to dryness. A 7.2 g portion of 3-(methylamino)-2-nitrobenzoic acid (3) was obtained as a red solid. The crude 3 was used in the next step without further purification. 1 H NMR (500 MHz) in CD 3 OD δ 2.96 (s, 3H), 6.80 (dd, J 1 = 1.5 Hz, J 2 = 7.5 Hz, 1H), 7.04 (dd, J 1 = 1.5 Hz, J 2 = 8.5 Hz, 1H), 7.46 (dd, J 1 = 7.5 Hz, J 2 = 8.5 Hz, 1H); 13 
Methyl 3-(methylamino)-2-nitrobenzoate (4)
A 1 g portion of crude 3-(methylamino)-2-nitrobenzoic acid (3) was suspended in 150 mL of Et 2 O. In a well-ventilated hood, diazomethane, generated by slow addition of 10% aq NaOH to a solution of Diazald (2 equiv) in EtOH, was bubbled into the ethereal solution under a stream of nitrogen until the reaction was complete, as evaluated by TLC. This reaction was repeated seven times on similar 1 g scales until all of the above crude material was converted. The combined red oil was purified by column chromatography (hexanes:EtOAc = 1:0, 10:1-4:1), giving 6.0 g (90% in two steps) of methyl 3-(methylamino)-2-nitrobenzoate (4) as a red oil. 1 
Methyl 2-amino-3-(methylamino)benzoate (5)
A mixture of methyl 3-(methylamino)-2-nitrobenzoate (4) (2.0 g, 9.5 mmol) and 10% Pd/C (100 mg, 5% w/w) in EtOAc/MeOH (50 mL/25 mL) was hydrogenated with hydrogen from a balloon for 60 h. The catalyst was removed by filtration through filter paper and the resulting solution was concentrated to dryness. Flash column chromatography of the residue (hexanes:EtOAc = 10:1-2:1) gave 1.43 g (83%) of methyl 2-amino-3-(methylamino)benzoate (5) 
Ligand L3
Pyridine (646 µL, 8 mmol, 40 equiv) was added to a suspension of diacid 6 (84.4 mg, 0.2 mmol) in anhydrous dichloromethane (80 mL) under an N 2 atmosphere. Thionyl chloride (584 µL, 8 mmol, 40 equiv) was added and the resulting solution was stirred at room temperature for 60 h. The volatiles were removed by rotary evaporation and the residue dried further under high vacuum for 8 h. To the resulting solid was added anhydrous dichloromethane (40 mL) and pyridine (646 µL, 8 mmol, 40 equiv), followed by methyl 2-amino-3-(methylamino)benzoate (5) (72 mg, 0.4 mmol, 2 equiv). The resulting light brown solution was stirred at room temperature for 30 h, after which all the volatiles were removed under vacuum. This crude material was used in the next step without further purification.
A solution of the above crude solid in HOAc (20 mL) was refluxed for 1 h. The acetic acid was removed under reduced pressure. The residue, purified by flash column chromatography with silica gel neutralized by Et 3 N (dichloromethane: EtOAc = 20:1-6:1), gave ligand L3 (68 mg, 48% in 3 steps) as a pale yellow solid. 1 In a nitrogen-filled glovebox, a solution of 2,6-bis(p-tolyl)benzoic acid (HO 2 CAr Tol ) (12.8 mg, 0.042 mmol, 1.0 equiv) in THF (2 mL) was added to a solution of Fe(OTf) 2 (MeCN) 2 (36.9 mg, 0.085 mmol, 2.0 equiv) in MeCN (2 mL), followed by addition of wet Et 3 N (11.7 µL, 0.085 mmol, 2.0 equiv). The mixture was stirred at room temperature for 5 min. The ligand L3 (30 mg, 0.042 mmol) dissolved in dichloromethane (2 mL) was added and the resulting red solution was stirred for 30 min. All the volatiles were removed under vacuum. The resulting yellow solid was dissolved in dichloromethane/MeOH (2 mL/0.5 mL) to form a dark red solution. 
UV-Vis Spectrophotometric Studies
Stock solutions of L3 (10 µM in dichloromethane), Fe(OTf) 2 (MeCN) 2 (4.0 mM in MeCN), Et 3 NHO 2 CAr Tol (4.0 mM, prepared by mixing equimolar amount of Et 3 N and HO 2 CAr Tol in THF), and carboxylate NaO 2 CCPh 3 (4.0 mM in MeOH) were prepared in a glovebox.
Reaction of L3 with Fe(OTf) 2 (MeCN) 2 -A 4.0 mL portion of the L3 stock solution was added to a UV-vis quartz cuvette, sealed tightly with a septum cap, and brought outside the glovebox. Aliquots (5 µL, 0.25 equiv relative to L3) of the Fe(OTf) 2 (MeCN) 2 stock solution were added via a 50 µL syringe through the septum seal into the cuvette. The cell was shaken gently before the electronic absorption spectra were recorded.
Reaction of the carboxylate ligand with a mixture of 2.0 equiv Fe(OTf) 2 (MeCN) 2 and L3-Inside a nitrogen-filled glovebox, a mixture containing 4 mL of L3 stock solution and 2.0 equiv Fe(OTf) 2 (MeCN) 2 stock solution was added to a UV-vis quartz cuvette, sealed tightly with a septum cap, and brought outside of the glovebox.
Aliquots (5 µL, 1.0 equiv relative to L3) of carboxylate in THF stock solution were added via a 50 µL syringe through the septum seal to the cuvette. The cell was shaken gently before the electronic absorption spectra were recorded.
Reaction of Fe(OTf) 2 (MeCN) 2 with a mixture of 1.0 equiv carboxylate and L3-Inside a nitrogen-filled glovebox, a mixture containing 4 mL of L3 stock solution and 1.0 equiv of the carboxylate stock solution was added to a UV-vis quartz cuvette, sealed tightly with a septum cap, and brought outside the glovebox. Aliquots (5 µL, 0.5 equiv relative to L3) of Fe(OTf) 2 (MeCN) 2 in MeCN stock solution were added via a 50 µL syringe through the septum seal to the cuvette. The cell was shaken gently before the electronic absorption spectra were recorded.
Results and Discussion

Ligand Design and Synthesis
We previously reported a unique dinucleating ligand having two benzoxazole N,O-donor arms linked through a rigid triptycene backbone (Figure 2, L1) . 36 With this ligand, we were able to crystallize and obtain structural data for the diiron complex, [Fe 2 L1(μ-OH)(μ-O 2 CAr Tol )(OTf) 2 ], where each iron atom is coordinated by the nitrogen atom of the benzoxazole and an oxygen atom from the ester. Because the active site of sMMOH utilizes carboxylate rather than ester groups, the analogous ligand, H 2 L2 Ph4 , which bears sterically protected bis(benzoxazole) diacid ligands, was synthesized. 47 The coordination of H 2 L2 Ph4 to iron in the presence of an external carboxylate afforded the unanticipated triiron complex, [NaFe 3 (L2 Ph4 ) 2 2 , having a "basic iron acetate" core. 47 A noteworthy feature of the [NaFe 3 (L2 Ph4 ) 2 2 structure is the lack of iron coordination at the nitrogen atoms of the benzoxazole arms. We hypothesized that these N atoms do not bind to the iron centers because of the low basicity of the benzoxazole moiety (pK b = 13.2). Much more basic nitrogen donors are provided by the bis(benzimidazole) ligand, L3 (Figure 2 ). The pK b of benzimidazole is 8.2, which is five orders of magnitude more basic than that of benzoxazole; this increase in basicity was expected to enhance the binding affinity of L3 for iron. The pK b of benzimidazole is also a better match to that of histidine (pK b ~ 8.0) compared to benzoxazole. From a biomimetic point of view, L3 more accurately matches the electronic properties of the coordinating residues present in the primary coordination sphere in BMM diiron active sites.
The synthetic route to benzimidazole ligand L3 requires preparation of methyl 2-amino-3-(methylamino)benzoate (5), which was obtained by according the route depicted in Scheme 1. Although 5 has an apparently simple structure, differentiation of its two nitrogen atoms via selective protection of nitrogen at the 3-position with a methyl group is a synthetic challenge. For instance, the direct functionalization of 2,3-diaminobenzoate by methylation or reductive amination would not be selective, giving low yields of the desired products and requiring difficult purification protocols. Although a procedure to replace the chlorine atom in 3-chloro-2-nitrobenzoic acid with methylamine under high pressure has been reported, 48 we obtained a mixture of compounds by this method. After performing a tedious recrystallization step, the product was isolated in very low yield. Therefore, this reaction is not practical for large-scale synthesis. To prepare large quantities of the desired diamine compound 5, several synthetic pathways were explored, ultimately leading to the discovery of an efficient route. The optimized synthesis of diamine 5 is delineated in Scheme 1. Methyl 3-chloro-2-nitrobenzoate (1) can be readily prepared from 3-chloro-2-nitrobenzoic acid in 99% yield, using diazomethane generated from Diazald and 10% aq NaOH in ethanol. A C-N bond coupling reaction of 1 with N-methylacetamide was achieved using Lindenschmidt's conditions, Pd(TFA) 2 , BINAP, and Cs 2 CO 3 . 49 Methyl 3-(N-methylacetamido)-2-nitrobenzoate (2) was obtained in high yield (82%) on a large scale. Next, hydrolysis of both the ester and amide groups with excess 10% aq NaOH in ethanol at 80 °C gave 3-(methylamino)-2-nitrobenzoic acid (3). Crude acid 3 was then treated with diazomethane to yield methyl 3-(methylamino)-2-nitrobenzoate (4) in 95% yield over two steps from 2. Lastly, hydrogenation of 4 afforded methyl 2-amino-3-(methylamino)benzoate (5) in 95% yield. This 5-step synthesis of diamine 5 is efficient, high-yielding (73% overall yield), and can be readily scaled up. Moreover, this approach can be utilized for the synthesis of diamine 5 analogs, facilitating the preparation of other L3 ligand variants.
With diamine 5 in hand, the amide coupling reaction between 5 and 6 was carried out (Scheme 2). 36 In contrast to the synthesis of benzoxazole ligand L1, the coupling reaction between diacid 6 and diamine 5 generated an inseparable mixture of compounds. Because compound 5 contains two different amine functionalities, several different products can be obtained depending on which amine group reacts to form the amide bond. The final cyclization step, however, is expected to yield the same product regardless of which amide bonds were present. Hence, cyclization of the crude mixture in glacial acetic acid afforded the desired ligand, L3, as the major product in 48% yield from diacid 6.
Three-component Titration Experiments
With diester ligand L3 in hand, we next explored its iron coordination chemistry. Because the active site of sMMOH contains two iron atoms surrounded by two nitrogen and four carboxylate donors, we wished to reproduce this stoichiometry in our model compounds. Although ligand L3 is designed to bind to two iron atoms, external carboxylate ligands are needed to complete the coordination sphere of the diiron core. To determine the ratio of iron(II) and external carboxylates that the L3 platform can accommodate, we carried out a series of UV-vis spectrophotometric titrations. 42, 50, 51 We first examined the coordination behavior of ligand L3 with an iron(II) salt in the absence of an external carboxylate ligand. As shown in Figure 3 , when various aliquots of Fe(OTf) 2 were added to a solution of L3 in dichloromethane, the absorption band at 345 nm decreased concomitant with increases at 365 and 386 nm, features that are characteristic of an Fe-O(H)-Fe species. The appearance of an isosbestic point at 308 nm indicates a single step conversion between two different species, suggesting that the apo L3 ligand binds to iron(II). These spectroscopic features did not change significantly when greater than 2.0 equiv of Fe(OTf) 2 were added (Figure 3, inset) . Although the exact iron-to-ligand ratio cannot be determined with certainty, these titration results reveal that ligand L3 can bind to more than one iron atom. This result is encouraging given that some other ligand systems developed in our laboratory could only produce complexes with a 1:1 iron-to-ligand ratio. 38, 42 We next sought to determine the stoichiometry of carboxylate binding to the diiron complex of L3. To a premixed solution containing L3 and Fe(OTf) 2 in a 1:2 ratio, the carboxylate Et 3 NHO 2 CAr Tol (triethylammonium 2,6-bis(p-tolyl)benzoate) was added in small portions and binding was monitored by UV-vis absorption spectroscopy. The addition of up to 1.0 equiv of Et 3 NHO 2 CAr Tol resulted in an increase in absorption bands at 365 and 386 nm. Figure 4a shows a plot of the absorption changes at 386 nm upon addition of Et 3 NHO 2 CAr Tol to L3. When greater than 1.0 equiv of the carboxylate were introduced, the band at 386 nm decreased while another appeared at 345 nm. The band at 345 nm arises from the free ligand, L3. We could reason that the addition of large excess of carboxylate leads to extrusion of iron from L3, forming iron carboxylate complexes and free L3. 18, 19 These studies suggested that only 1.0 equiv of carboxylate should be utilized to prepare diiron complexes supported by L3.
To investigate whether the ratio of iron, external carboxylates, and L3 depends on the order of addition, a final set of titrations was carried out by adding Fe(OTf) 2 to a premixed solution of L3 and Et 3 NHO 2 CAr Tol (1:1). Figure 4b shows a plot of the UV-vis absorbance changes at 386 nm following addition of Fe(OTf) 2 to L3/Et 3 NHO 2 CAr Tol . The absorbance increased linearly until 2.0 equiv of Fe(OTf) 2 were added. Treatment with additional equivalents of Fe(OTf) 2 led to a slight decrease in the absorption at 386 nm, which is most likely a result of competitive binding of excess Fe(II) to the external carboxylate groups.
Similar titration experiments were carried out using sodium 2,2,2-triphenylacetate instead of 2,6-bis(tolyl)benzoate and yielded comparable results (Figures 4c and 4d ). Taken together, these studies suggest that at least one external carboxylate can bind to a diiron-L3 complex.
Iron Complexes of L3
By combining L3, carboxylate, and iron(II) in a 1:1:2 ratio, as determined to be necessary for diiron complex formation according to the titration experiments described above, crystals of [ (9), 36 exhibits some notable differences from that of the benzimidazole analogs 7 and 8. A comparison of relevant structural parameters of these three complexes is provided in Table 2 . Even though a more strongly donating benzimidazole ligand is present in 7 and 8, the Fe-N distances of approximately 2.1 Å are similar to those in the benzoxazole structure. The other Fe-L distances are similar as well. The parameter, τ (eq 1), provides an assessment of a five-coordinate structure having a geometry between that of an idealized trigonal-bipyramid (τ = 1) vs a square-pyramid (τ = 0). [52] [53] [54] The τ values for the iron atoms in 7-9 are summarized in Table 2 . The two iron atoms of 7 attain a near perfect square-pyramidal coordination geometry as evidenced by τ values close to 0 (0.05 and 0.08). The iron atoms of 8 and 9 exhibit a higher degree of distortion toward trigonal-bipyramidal stereochemistry. The τ values for 8 are 0.20 and 0.30, whereas those for 9 are 0.30 and 0.41. The greater distortion of 9 toward trigonal-pyramidal geometry may be a consequence of the weaker donor ability of the benzoxazole nitrogen atoms. Although compounds 7 and 8 have a hydroxo-bridged diiron(II) core, similar electronic effects may be at play in determining the coordination geometry. Another significant difference between the benzimidazole structures 7 and 8 and the benzoxazole structure 9 is the presence of weak interactions at the available remaining coordination sites at the Fe(II) centers and the oxygen atoms of the furan ring (O1 and O2). In 9, these Fe-O distances are 2.987 and 3.060 Å ( Table 2 ). For 7 and 8 these distances contract significantly. The Fe-O distances in these complexes range from 2.610 to 2.860 Å. These shorter distances could in part be due to more rigorous square-pyramidal geometry enforced by the benzimidazole ligands. (1) The dinucleating ligand conformations are similar for structures 7-9 ( Table 2 ). The distance between nitrogen donor atoms (N1⋯N2) varies from 7.233 to 7.335 Å, whereas the distances between furan oxygen atoms (O1⋯O2) fall between 5.076 and 5.165 Å. These small structural variations reflect the pre-organization of the triptycene backbone. Rotation about the C-C bond between the benzofuran backbone and the benzoxazole or benzimidazole arms of the ligands will allow for some structural flexibility, however, as may be required for efficient metal coordination. These dihedral angles in 9 are 2.69 and 3.76° for the two arms. In the benzimidazole structures the analogous dihedral angles range from 4.47 to 7.70°, indicating somewhat greater distortion from coplanarity of the two π systems. This subtle change in dihedral angle may be a consequence of the preferred coordination geometry of the benzimidazole compared to the benzoxazole structures.
Mössbauer Spectra of Complexes 7 and 8
Zero-field 57 Fe Mössbauer spectra of polycrystalline samples of complexes 7 and 8 were recorded at 77 K. Both spectra show a single quadrupole doublet. Table 4 lists the parameters of complexes 7 and 8. As shown in Figure 7 , the isomer shift (δ) of 7 is 1.218 mm·s −1 and the quadrupole splitting (ΔE Q ) is 1.960 mm·s −1 . These parameters are characteristic of high spin diiron(II) complexes. The values compare favorably to those for the benzoxazole analog 9, which has an isomer shift of 1.214 mm·s −1 and a quadrupole splitting of 1.925 mm·s −1 . In addition, the isomer shift (δ) of 8 is 1.224 mm·s −1 and the quadrupole splitting (ΔE Q ) is 2.064 mm·s −1 . Although the solid-state structures indicate slightly different coordination geometries at the two iron centers, these differences have a minimal effect on electronic properties, as reflected by a single isomer shift.
Conclusions
With the goal of increasing the electron-donating properties of our first generation triptycene-based ligand, L1, we designed and synthesized an analogous ligand, L3, which introduces a more basic benzimidazole nitrogen donor in place of the benzoxazole nitrogen donor of L1. Ligand L3 was obtained in a 15-step convergent synthesis. Titration experiments were conducted to determine the appropriate combination of iron(II), carboxylate, and L3 required to assemble a diiron complex. The X-ray crystal structures of two such carboxylate-bridged diiron complexes reveal that L3 binds to a diiron unit in a fashion similar to that of L1. Complexes of L3 exhibit some structural differences in comparison to those of L1. Most notably, the diiron complexes 7 and 8 feature coordination geometries closer to square-pyramidal and a close Fe-O interaction with benzofuran backbone. The iron oxidation states of the new complexes were confirmed by utilizing Mössbauer spectroscopy. Ongoing work is focused on the hydrolysis of the ester moieties of L3 to form a more biomimetic carboxylate ligand. Ligands employed in diiron modeling. More basic benzimidazole ligand. UV-vis absorption spectra obtained from addition of Fe(OTf) 2 (0.5 equiv each) to L3 (10 µM in dichloromethane). The inset shows the absorbance changes at 386 nm, where the error bars for each data point were calculated from triplicate experiments. (7) with 50% probability thermal ellipsoid and a partial numbering scheme. Hydrogen atoms and solvent molecules are omitted for clarity. Iron, green; carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow; fluorine, yellow green. Selected bond lengths (Å) and angles (deg): Fe1-N1, 2.084(6); Fe2-N2, 2.100(6); Fe1-O5, 2.091(6); Fe2-O7, 2. Zero-field 57 Fe Mössbauer spectrum of complex 7 recorded at 77 K.
Scheme 1.
Diaminobenzoate synthesis.
Scheme 2.
Ligand L3 synthesis. 
